Unique ID issued by UMIN | UMIN000016777 |
---|---|
Receipt number | R000019466 |
Scientific Title | The beneficial effect of a newly developed functional food (beverage) containing Lactobacillus powder on human gastrointestinal function. |
Date of disclosure of the study information | 2015/03/12 |
Last modified on | 2017/01/25 17:29:52 |
The beneficial effect of a newly developed functional food (beverage) containing Lactobacillus powder on human gastrointestinal function.
The beneficial effect of a beverage containing Lactobacillus powder on human gastrointestinal function.
The beneficial effect of a newly developed functional food (beverage) containing Lactobacillus powder on human gastrointestinal function.
The beneficial effect of a beverage containing Lactobacillus powder on human gastrointestinal function.
Japan |
Individuals with a tendency for constipation or loose stool
Not applicable |
Others
NO
In order to investigate the efficacy and safety of the intake of the test beverages for 3 weeks on persons with constipation or frequent loose stool.
Safety,Efficacy
Defecation frequency, defecation days, fecal condition
Intestinal microflora composition, organic acids, putrefactive products, questionnaire for QOL
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
Intervention
Test beverage (containing Lactobacillus powder)
Duration: 3 weeks
Amount: 200 mL/ bottle, 1 bottle daily
Control
Placebo beverage
Duration: 3 weeks
Amount: 200 mL/ bottle, 1 bottle daily
20 | years-old | <= |
70 | years-old | > |
Male and Female
(1) Japanese males and females from 20 to 70 years of age.
(2) Those with a tendency for constipation (at 4 times or less of defecation per week), and for loose stool (at 10 times or more of defecation per week).
(3) Those taking regular meals.
(1) A medical history of severe disorders, or continuous medical treatment.
(2) A surgical history of digestive system (except appendicectomy)
(3) Watery stool daily
(4) Those who are pregnant or have possibility to become pregnant during the study or breast-feeding.
(5) Constantly usage of supplements and/or functional foods (including Food for Specified Health Uses [FOSHU]) affecting the test results.
(6) Those having an extremely irregular diet habit, alternative work schedule, or work on midnight shift.
(7) Those who drink alcohol a lot.
(8) Withdrawal of whole blood more than 400mL within 12 weeks, or more than 200mL within 4 weeks, or withdrawal of blood components prior to the current study.
(9) Those judged as unsuitable for the study by the principal investigator for other reasons.
120
1st name | |
Middle name | |
Last name | Kazuhiko Takano |
Medical Corporation Hokubukai
Utsukushigaoka Hospital
61-1 Sin-ei, Kiyota-ku, Sapporo, Hokkaido 004-0839, Japan
001-882-0111
info@csc-smo.co.jp
1st name | |
Middle name | |
Last name | Isao Takehara |
Clinical Support Corporation
PI-Food Service Division
4-1 South 1 West 8, Chuo-ku, Sapporo, Hokkaido 060-0061, Japan
011-223-3130
takehara@csc-smo.co.jp
Clinical Support Corporation
Asahi Group Holdings Ltd.
Profit organization
Calpis Co. Ltd.
NO
2015 | Year | 03 | Month | 12 | Day |
Published
http://www.microbecolhealthdis.net/index.php/mehd/article/view/30259
Completed
2015 | Year | 02 | Month | 12 | Day |
2015 | Year | 03 | Month | 12 | Day |
2015 | Year | 03 | Month | 11 | Day |
2017 | Year | 01 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019466